The
currently existing magnetic hyperthermia treatments usually
need to employ very large doses of magnetic nanoparticles (MNPs) and/or
excessively high excitation conditions (
H
×
f
> 10
10
A/m s) to reach the therapeutic temperature
range that triggers cancer cell death. To make this anticancer therapy
truly minimally invasive, it is crucial the development of improved
chemical routes that give rise to monodisperse MNPs with high saturation
magnetization and negligible dipolar interactions. Herein, we present
an innovative chemical route to synthesize Zn-doped magnetite NPs
based on the thermolysis of two kinds of organometallic precursors:
(i) a mixture of two monometallic oleates (FeOl + ZnOl), and (ii)
a bimetallic iron-zinc oleate (Fe
3–
y
Zn
y
Ol). These approaches have allowed
tailoring the size (10–50 nm), morphology (spherical, cubic,
and cuboctahedral), and zinc content (Zn
x
Fe
3–
x
O
4
, 0.05 <
x
< 0.25) of MNPs with high saturation magnetization
(≥90 Am
2
/kg at RT). The oxidation state and the
local symmetry of Zn
2+
and Fe
2+/3+
cations have
been investigated by means of X-ray absorption near-edge structure
(XANES) spectroscopy, while the Fe center distribution and vacancies
within the ferrite lattice have been examined in detail through Mössbauer
spectroscopy, which has led to an accurate determination of the stoichiometry
in each sample. To achieve good biocompatibility and colloidal stability
in physiological conditions, the Zn
x
Fe
3–
x
O
4
NPs have been coated
with high-molecular-weight poly(ethylene glycol) (PEG). The magnetothermal
efficiency of Zn
x
Fe
3–
x
O
4
@PEG samples has been systematically
analyzed in terms of composition, size, and morphology, making use
of the latest-generation AC magnetometer that is able to reach 90
mT. The heating capacity of Zn
0.06
Fe
2.9
4
O
4
cuboctahedrons of 25 nm reaches a maximum value
of 3652 W/g (at 40 kA/m and 605 kHz), but most importantly, they reach
a highly satisfactory value (600 W/g) under strict safety excitation
conditions (at 36 kA/m and 125 kHz). Additionally, the excellent heating
power of the system is kept identical both immobilized in agar and
in the cellular environment, proving the great potential and reliability
of this platform for magnetic hyperthermia therapies.